Abstract
The present application relates to a process for the preparation of 2,2',2''-(1,4,7,10-Tetraazacyclododecane-1,4,7-triyl)triacetic acid represented by the following structural formula-3.
Formula-3.
Present disclosure also describes a novel crystalline form of Calteridol calcium and its process for the preparation.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan; Sagyam Rajeshwar Reddy; Velishala Praveen and Vadlakonda Srikanth., "Process for the preparation of Gadolinium-based contrast agents and its intermediates", Technical Disclosure Commons, (December 15, 2025)
https://www.tdcommons.org/dpubs_series/9037